INTELLIGENT BIO SOLUTIONS INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $4.2M | $3.1M | $3.1M | $1.3M | $437.1K | $2.0M | $188.7K |
| Cost of Revenue | $2.2M | $1.8M | $1.7M | $930.2K | — | — | — |
| Gross Profit | $2.0M | $1.2M | $1.4M | $326.7K | — | — | — |
| Gross Margin | 48.6% | 40.8% | 45.8% | 26.0% | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $10.5M | $8.9M | $9.3M | $8.0M | $4.9M | $3.4M | $2.2M |
| Operating Income | $-12.6M | $-10.7M | $-10.3M | $-12.6M | $-8.3M | $-5.6M | $-2.9M |
| Operating Margin | -299.1% | -349.8% | -330.5% | -1,002.1% | -1,907.1% | -281.4% | -1,513.7% |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | $-7.1M | $-3.2M |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | $-12.4M | $-10.6M | $-10.2M | $-10.6M | $-8.3M | $-7.0M | $-3.2M |
| Net Margin | -294.9% | -346.2% | -326.4% | -845.9% | -1,900.1% | -355.3% | -1,676.2% |
| EPS (Basic) | $-8.44 | $-6.68 | $-2.13 | $-2.23 | $-0.20 | $-0.01 | $-0.01 |
| EPS (Diluted) | $-8.44 | $-6.68 | $-2.13 | $-2.23 | $-0.20 | $-0.01 | $-0.01 |
| Shares Outstanding (Basic) | 1.5M | 1.6M | 4.8M | 4.8M | 41.8M | 593.6M | 491.9M |
| Shares Outstanding (Diluted) | 1.5M | 1.6M | 4.8M | 4.8M | 41.8M | 593.6M | 491.9M |
| Dividends Per Share | — | — | — | — | — | — | — |